{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:33:25Z","timestamp":1775165605426,"version":"3.50.1"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.smim.2022.101601","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T08:17:44Z","timestamp":1645604264000},"page":"101601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)"],"prefix":"10.1016","volume":"59","author":[{"given":"Luciana P\u00e1dua","family":"Tavares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza Mathias","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1042-9762","authenticated-orcid":false,"given":"Lirl\u00e2ndia Pires","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro Martins","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7203","key":"10.1016\/j.smim.2022.101601_bib0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2141.2005.05462.x","article-title":"Susceptibility to infection in patients with neutropenia: the role of the innate immune system","volume":"129","author":"Neth","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-065X.2011.01077.x","article-title":"Adapting to environmental stresses: the role of the microbiota in controlling innate immunity and behavioral responses","volume":"245","author":"Fagundes","year":"2012","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0020","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ajpath.2013.02.027","article-title":"Inflammatory and innate immune responses in dengue infection: protection versus disease induction","volume":"182","author":"Costa","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.smim.2022.101601_bib0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","article-title":"Mediators of the resolution of the inflammatory response","volume":"40","author":"Sugimoto","year":"2019","journal-title":"Trends Immunol."},{"issue":"55","key":"10.1016\/j.smim.2022.101601_bib0030","first-page":"479","article-title":"The development of anti-inflammatory drugs for infectious diseases","volume":"10","author":"Garcia","year":"2010","journal-title":"Discov. Med."},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0035","doi-asserted-by":"crossref","first-page":"e1001171","DOI":"10.1371\/journal.ppat.1001171","article-title":"Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice","volume":"6","author":"Garcia","year":"2010","journal-title":"PLoS Pathog."},{"issue":"33","key":"10.1016\/j.smim.2022.101601_bib0040","doi-asserted-by":"crossref","first-page":"14138","DOI":"10.1073\/pnas.0906467106","article-title":"Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection","volume":"106","author":"Souza","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.smim.2022.101601_bib0045","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fimmu.2017.01799","article-title":"CXCR1\/2 antagonism is protective during influenza and post-influenza pneumococcal infection","volume":"8","author":"Tavares","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2022.101601_bib0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/eji.201747198","article-title":"CXCR2 is critical for bacterial control and development of joint damage and pain in Staphylococcus aureus-induced septic arthritis in mouse","volume":"48","author":"Boff","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2022.101601_bib0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2022.101601_bib0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of inflammation: what controls its onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2022.101601_bib0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.coph.2013.03.007","article-title":"Pharmacological strategies to resolve acute inflammation","volume":"13","author":"Sousa","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pharmthera.2013.04.006","article-title":"Resolution of inflammation: mechanisms and opportunity for drug development","volume":"139","author":"Alessandri","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","article-title":"Resolution pharmacology: opportunities for therapeutic innovation in inflammation","volume":"36","author":"Perretti","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"5703","key":"10.1016\/j.smim.2022.101601_bib0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/278456a0","article-title":"Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation","volume":"278","author":"Flower","year":"1979","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.1983.tb10526.x","article-title":"Characterization and partial purification of\u2019 renocortins\u2019: two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids","volume":"79","author":"Cloix","year":"1983","journal-title":"Br. J. Pharmacol."},{"issue":"6127","key":"10.1016\/j.smim.2022.101601_bib0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/328270a0","article-title":"Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung","volume":"328","author":"Cirino","year":"1987","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2022.101601_bib0105","doi-asserted-by":"crossref","first-page":"8239258","DOI":"10.1155\/2016\/8239258","article-title":"Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance","volume":"2016","author":"Sugimoto","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrm1661","article-title":"Annexins: linking Ca2+ signalling to membrane dynamics","volume":"6","author":"Gerke","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"33","key":"10.1016\/j.smim.2022.101601_bib0115","doi-asserted-by":"crossref","first-page":"13758","DOI":"10.1074\/jbc.M117.800391","article-title":"The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1","volume":"292","author":"Lima","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0120","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1182\/blood-2008-02-140533","article-title":"Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles","volume":"112","author":"Dalli","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.smim.2022.101601_bib0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0022-2836(03)00027-5","article-title":"A calcium-driven conformational switch of the N-terminal and core domains of annexin A1","volume":"326","author":"Rosengarth","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"20","key":"10.1016\/j.smim.2022.101601_bib0130","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.15212","article-title":"Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology","volume":"177","author":"Perretti","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"41","key":"10.1016\/j.smim.2022.101601_bib0135","doi-asserted-by":"crossref","first-page":"29998","DOI":"10.1074\/jbc.M702876200","article-title":"Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3","volume":"282","author":"Vong","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.smim.2022.101601_bib0140","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1096\/fj.05-5319fje","article-title":"Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface","volume":"20","author":"Solito","year":"2006","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.smim.2022.101601_bib0145","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.4049\/jimmunol.1500886","article-title":"Proresolving actions of synthetic and natural protease inhibitors are mediated by annexin A1","volume":"196","author":"Vago","year":"2016","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.189.2.395","article-title":"A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells","volume":"189","author":"Su","year":"1999","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/mol.110.068288","article-title":"Gastrin-releasing peptide\/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors","volume":"79","author":"Schepetkin","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.smim.2022.101601_bib0160","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","article-title":"Illuminating G-Protein-Coupling selectivity of GPCRs","volume":"177","author":"Inoue","year":"2019","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.smim.2022.101601_bib0165","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1073\/pnas.1308253110","article-title":"Ligand-specific conformational change of the G-protein-coupled receptor ALX\/FPR2 determines proresolving functional responses","volume":"110","author":"Cooray","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"45","key":"10.1016\/j.smim.2022.101601_bib0170","doi-asserted-by":"crossref","first-page":"18033","DOI":"10.1073\/pnas.1317798110","article-title":"Biasing the lipoxin A4\/formyl peptide receptor 2 pushes inflammatory resolution","volume":"110","author":"Filep","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.smim.2022.101601_bib0175","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI124635","article-title":"Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation","volume":"130","author":"McArthur","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI65831","article-title":"Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair","volume":"123","author":"Leoni","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2022.101601_bib0185","doi-asserted-by":"crossref","first-page":"105030","DOI":"10.1016\/j.phrs.2020.105030","article-title":"Blame the signaling: role of cAMP for the resolution of inflammation","volume":"159","author":"Tavares","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.smim.2022.101601_bib0190","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood-2016-09-742825","article-title":"Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1","volume":"129","author":"Sugimoto","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/rcmb.2015-0083OC","article-title":"Inhibition of Phosphodiesterase-4 during pneumococcal pneumonia reduces inflammation and lung injury in mice","volume":"55","author":"Tavares","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"10","key":"10.1016\/j.smim.2022.101601_bib0200","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.4049\/jimmunol.1401722","article-title":"The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution","volume":"194","author":"Vago","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1189\/jlb.0112008","article-title":"Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis","volume":"92","author":"Vago","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0210","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.bbamcr.2006.08.041","article-title":"Proteolytic cleavage of annexin 1 by human leukocyte elastase","volume":"1763","author":"Rescher","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"20","key":"10.1016\/j.smim.2022.101601_bib0215","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1182\/blood-2010-02-270520","article-title":"Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature","volume":"116","author":"Pederzoli-Ribeil","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1559-0275-10-14","article-title":"Proteomic profiling of serum samples from chikungunya-infected patients provides insights into host response","volume":"10","author":"Puttamallesh","year":"2013","journal-title":"Clin. Proteomics"},{"issue":"10","key":"10.1016\/j.smim.2022.101601_bib0225","doi-asserted-by":"crossref","first-page":"e14606","DOI":"10.1111\/ijcp.14606","article-title":"Annexin A1 as a potential prognostic biomarker for COVID-19 disease: case-control study","volume":"75","author":"Canacik","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12879-021-05917-y","article-title":"Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM\/TSP","volume":"21","author":"Santana","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.smim.2022.101601_bib0235","doi-asserted-by":"crossref","first-page":"104809","DOI":"10.1016\/j.antiviral.2020.104809","article-title":"The involvement of annexin A1 in human placental response to maternal Zika virus infection","volume":"179","author":"Molas","year":"2020","journal-title":"Antiviral Res."},{"issue":"52","key":"10.1016\/j.smim.2022.101601_bib0240","doi-asserted-by":"crossref","first-page":"18685","DOI":"10.1073\/pnas.1410938111","article-title":"Nonredundant protective properties of FPR2\/ALX in polymicrobial murine sepsis","volume":"111","author":"Gobbetti","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.smim.2022.101601_bib0245","series-title":"International Encyclopedia of Public Health","first-page":"273","article-title":"Bacterial infections: overview","author":"Doron","year":"2008"},{"key":"10.1016\/j.smim.2022.101601_bib0250","unstructured":"and Strategy Unit. ;, C.f.D.C.a.P.U.S.N.C.f.E.Z.a.I.D.U.S.D.o.H.Q.P.A.R.C., Antibiotic resistance threats in the United States, 2019, in Stephen B. Thacker CDC Library collection. 2019."},{"issue":"3","key":"10.1016\/j.smim.2022.101601_bib0255","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00680-20","article-title":"Annexin A1 attenuates neutrophil migration and IL-6 expression through Fpr2 in a mouse model of Streptococcus suis-Induced meningitis","volume":"89","author":"Ni","year":"2021","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0260","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1096\/fj.201902172R","article-title":"The Annexin A1\/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia","volume":"34","author":"Machado","year":"2020","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0265","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI77014","article-title":"Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection","volume":"125","author":"Tzelepis","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.smim.2022.101601_bib0270","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.imbio.2014.12.001","article-title":"Absence of Annexin A1 impairs host adaptive immunity against Mycobacterium tuberculosis in vivo","volume":"220","author":"Vanessa","year":"2015","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0275","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0002-9440(10)62471-6","article-title":"Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation","volume":"166","author":"Damazo","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.smim.2022.101601_bib0280","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jcma.2013.05.004","article-title":"Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin","volume":"76","author":"Tsai","year":"2013","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.smim.2022.101601_bib0285","doi-asserted-by":"crossref","first-page":"e20200277","DOI":"10.1590\/0037-8682-0277-2020","article-title":"Expression of annexin-A1 in blood and tissue leukocytes of leprosy patients","volume":"53","author":"Ribeiro","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.smim.2022.101601_bib0290","doi-asserted-by":"crossref","first-page":"672026","DOI":"10.3389\/fmicb.2021.672026","article-title":"Acute infection of viral pathogens and their innate immune escape","volume":"12","author":"Rai","year":"2021","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.smim.2022.101601_bib0300","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"issue":"25","key":"10.1016\/j.smim.2022.101601_bib0305","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0310","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaci.2018.04.004","article-title":"Dexamethasone induces omega3-derived immunoresolvents driving resolution of allergic airway inflammation","volume":"142","author":"Pyrillou","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0315","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112473","article-title":"Targeting AnxA1\/Formyl peptide receptor 2 pathway affords protection against pathological thrombo-inflammation","volume":"9","author":"Vital","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0320","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.2020009166","article-title":"Targeting the AnxA1\/Fpr2\/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease","volume":"137","author":"Ansari","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.smim.2022.101601_bib0325","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/bph.13109","article-title":"Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice","volume":"172","author":"Trentin","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.smim.2022.101601_bib0330","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.intimp.2018.08.011","article-title":"Mimetic peptide AC2-26 of annexin A1 as a potential therapeutic agent to treat COPD","volume":"63","author":"Possebon","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0335","first-page":"71","article-title":"Annexin A1 negatively regulates viral RNA replication of hepatitis C virus","volume":"69","author":"Hiramoto","year":"2015","journal-title":"Acta Med. Okayama"},{"issue":"8","key":"10.1016\/j.smim.2022.101601_bib0340","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1301504","article-title":"Annexin-A1 regulates TLR-mediated IFN-beta production through an interaction with TANK-binding kinase 1","volume":"191","author":"Bist","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2022.101601_bib0345","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/cdd.2016.19","article-title":"Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis","volume":"23","author":"Arora","year":"2016","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.smim.2022.101601_bib0350","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1096\/fj.201700584RR","article-title":"Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-beta-STAT3-dependent pathway","volume":"32","author":"Ampomah","year":"2018","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0355","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1096\/fj.201901265R","article-title":"The annexin A1\/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model","volume":"33","author":"Schloer","year":"2019","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.smim.2022.101601_bib0360","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0365","doi-asserted-by":"crossref","first-page":"12703","DOI":"10.1038\/s41598-021-92220-0","article-title":"Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients","volume":"11","author":"Shafran","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.smim.2022.101601_bib0370","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Simoes e Silva","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.smim.2022.101601_bib0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1 Pt 2","key":"10.1016\/j.smim.2022.101601_bib0380","first-page":"H324","article-title":"Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats","volume":"257","author":"Campagnole-Santos","year":"1989","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0385","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.smim.2022.101601_bib0390","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.smim.2022.101601_bib0395","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.smim.2022.101601_bib0400","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang","year":"2014","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0405","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1161\/01.ATV.0000140059.04717.f3","article-title":"Angiotensin II-induced insulin resistance and protein tyrosine phosphatases","volume":"24","author":"Marrero","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.smim.2022.101601_bib0410","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.HYP.37.4.1141","article-title":"Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"37","author":"Clark","year":"2001","journal-title":"Hypertension"},{"issue":"49","key":"10.1016\/j.smim.2022.101601_bib0415","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1073\/pnas.1612668113","article-title":"Role of the receptor Mas in macrophage-mediated inflammation in vivo","volume":"113","author":"Hammer","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0420","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147819","article-title":"Angiotensin-(1-7)\/MasR axis promotes migration of monocytes\/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis","volume":"7","author":"Zaidan","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jnc.13386","article-title":"Direct anti-inflammatory effects of angiotensin-(1-7) on microglia","volume":"136","author":"Liu","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.smim.2022.101601_bib0430","doi-asserted-by":"crossref","first-page":"105292","DOI":"10.1016\/j.phrs.2020.105292","article-title":"Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection","volume":"163","author":"Melo","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.smim.2022.101601_bib0435","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2018.00058","article-title":"Angiotensin-(1-7) promotes resolution of eosinophilic inflammation in an experimental model of asthma","volume":"9","author":"Magalhaes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2022.101601_bib0440","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3389\/fimmu.2017.01596","article-title":"Angiotensin-(1-7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice","volume":"8","author":"Barroso","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0445","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1476-5381.2012.01905.x","article-title":"Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1\/2- and NF-kappaB-dependent pathways","volume":"166","author":"El-Hashim","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0450","doi-asserted-by":"crossref","first-page":"e66082","DOI":"10.1371\/journal.pone.0066082","article-title":"Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy","volume":"8","author":"Silveira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2022.101601_bib0455","doi-asserted-by":"crossref","first-page":"2401081","DOI":"10.1155\/2019\/2401081","article-title":"Angiotensin-(1-7) and alamandine promote anti-inflammatory response in macrophages in vitro and in vivo","volume":"2019","author":"de Carvalho Santuchi","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"9","key":"10.1016\/j.smim.2022.101601_bib0460","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/bph.13057","article-title":"Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation","volume":"172","author":"Magalhaes","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0465","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-018-2210-y","article-title":"Angiotensin-(1-7) attenuates organ injury and mortality in rats with polymicrobial sepsis","volume":"22","author":"Tsai","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.smim.2022.101601_bib0470","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3389\/fimmu.2019.02885","article-title":"Improving the innate immune response in diabetes by modifying the renin angiotensin system","volume":"10","author":"Soto","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2022.101601_bib0475","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis","volume":"185","author":"da Silveira","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0480","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/HYPERTENSIONAHA.109.143255","article-title":"Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide\/guanosine 3\u2019,5\u2019-cyclic monophosphate-dependent pathway","volume":"55","author":"Gomes","year":"2010","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.smim.2022.101601_bib0485","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/01.hjh.0000244945.42169.c0","article-title":"The role of angiotensin(1-7) in renal vasculature of the rat","volume":"24","author":"van der Wouden","year":"2006","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0490","first-page":"931","article-title":"Ang(1-7) treatment attenuates beta-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes","volume":"36","author":"Yuan","year":"2013","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.smim.2022.101601_bib0495","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.smim.2022.101601_bib0500","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.peptides.2013.05.010","article-title":"Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin\/TLR4\/MAPK\/NF-kappaB in rats fed with high-fat diet","volume":"46","author":"Santos","year":"2013","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.smim.2022.101601_bib0505","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","article-title":"Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia","volume":"167","author":"Jiang","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.smim.2022.101601_bib0510","doi-asserted-by":"crossref","first-page":"F784","DOI":"10.1152\/ajprenal.00455.2011","article-title":"Angiotensin-(1-7)-induced activation of ERK1\/2 is cAMP\/protein kinase A-dependent in glomerular mesangial cells","volume":"302","author":"Liu","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0515","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1165\/rcmb.2008-0091TR","article-title":"Cyclic AMP: master regulator of innate immune cell function","volume":"39","author":"Serezani","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.smim.2022.101601_bib0520","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"7047","key":"10.1016\/j.smim.2022.101601_bib0525","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.smim.2022.101601_bib0530","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2022.101601_bib0535","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/JIR.S307801","article-title":"The ACE2-Ang-(17)-Mas Axis Modulates M1\/M2 macrophage polarization to relieve CLP-Induced inflammation via TLR4-Mediated NF-small ka, cyrillicb and MAPK pathways","volume":"14","author":"Pan","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"604","key":"10.1016\/j.smim.2022.101601_bib0540","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2138","article-title":"An ACE inhibitor reduces bactericidal activity of human neutrophils in vitro and impairs mouse neutrophil activity in vivo","volume":"13","author":"Cao","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.smim.2022.101601_bib0545","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101614","article-title":"Angiotensin-(1-7) peptide hormone reduces inflammation and pathogen burden during Mycoplasma pneumoniae infection in mice","volume":"13","author":"Collins","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.smim.2022.101601_bib0550","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.4049\/jimmunol.1900579","article-title":"A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to Pseudomonas aeruginosa lung infection in mice","volume":"203","author":"Sodhi","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101601_bib0555","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lfs.2018.07.013","article-title":"Sini decoction alleviates E. Coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis","volume":"208","author":"Liu","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.smim.2022.101601_bib0560","series-title":"Pediatric Nephrology: Sixth Completely Revised, Updated and Enlarged Edition","first-page":"1235","article-title":"Infectious diseases and the kidney","author":"Herberg","year":"2009"},{"issue":"4","key":"10.1016\/j.smim.2022.101601_bib0565","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.smim.2022.101601_bib0570","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0575","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.smim.2022.101601_bib0580","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1164\/rccm.202101-0142LE","article-title":"ACE2 elevation in severe COVID-19","volume":"203","author":"Reindl-Schwaighofer","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101601_bib0585","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/jmv.26479","article-title":"Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7","volume":"93","author":"Henry","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.smim.2022.101601_bib0590","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/ncomms4595","article-title":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients","volume":"5","author":"Huang","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.smim.2022.101601_bib0595","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.4049\/jimmunol.1203000","article-title":"Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2\/lipoxin A4 receptor","volume":"190","author":"Dalli","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2022.101601_bib0600","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.110.167346","article-title":"An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats","volume":"57","author":"Marques","year":"2011","journal-title":"Hypertension"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:22:08Z","timestamp":1760916128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532322000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":120,"alternative-id":["S1044532322000185"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2022.101601","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2022.101601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101601"}}